
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical solution containing lactic acid, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products contain lactic acid itself only in combination with other active ingredients, in injection and gel forms. Its ammonium salt, ammonium lactate, is FDA-approved on its own as a lotion and as a cream. No FDA-approved lactic acid product is listed in solution form; solution products containing it are filed as homeopathic products.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Lactic acid is an alpha hydroxy acid used on the skin as a moisturizer and exfoliant; compounding pharmacies prepare it by prescription.
Lactic acid (2-hydroxypropanoic acid) is an alpha hydroxy acid that occurs naturally in foods and is a normal part of the body's tissues and blood. FDA affirms it as generally recognized as safe as a direct food ingredient, except in infant foods and infant formulas. On the skin, alpha hydroxy acids act as humectants that may increase hydration of the outer skin layer and may reduce cohesion between surface skin cells. Ammonium lactate cream, 12%, which contains a salt of lactic acid, is FDA-approved for ichthyosis vulgaris and xerosis (dry, scaly skin). Lactic acid is also one of the most common AHAs in cosmetics and is a component of Jessner peel solution. A prescriber might order lactic acid compounded for a concentration, vehicle or combination not available commercially. Compounded preparations are not FDA-approved and require a prescription.
The ammonium lactate cream label says to minimize or avoid sun exposure on treated skin and to stop use if hypersensitivity occurs; it is contraindicated in people allergic to any of its ingredients. Stinging or burning may occur on skin that is cracked, eroded or abraded, such as after shaving, and caution is advised on the face because of the potential for irritation. FDA has received reports of burning, rash, swelling and pigment changes with AHA products and recommends a "Sunburn Alert": use sunscreen, wear protective clothing and limit sun exposure during use and for a week afterward. The label notes lactic acid is a normal part of blood and tissues but says it is not known how the cream affects lactic acid levels in breast milk, so caution is advised when nursing. Stop use and talk to your prescriber or pharmacist if you develop burning, swelling or rash.
Lactic acid is an alpha hydroxy acid; the ammonium lactate label describes humectant action that may influence stratum corneum hydration and may decrease corneocyte cohesion, by mechanisms not yet known. In an in vitro study with human cadaver skin, about 6.1% of applied ammonium lactate cream was absorbed after 68 hours. Labeled indication: ammonium lactate cream, 12%, for ichthyosis vulgaris and xerosis. StatPearls describes lactic acid as a component of Jessner solution, a peel agent used primarily for acne and hyperkeratotic lesions; peel use is not an FDA-approved indication. The Tang and Yang review notes that AHA concentration, pH, exposure time and free acid content shape skin response, and that topical AHAs can increase photosensitivity to UVB. FDA summarizes the Cosmetic Ingredient Review panel's finding that glycolic and lactic acid products are safe for consumers within limits on concentration and pH and with sun protection. Concentration, pH and contact time are per prescriber. Monitor for irritation, especially on fissured or abraded skin, and counsel daily sun protection.
Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.
Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)